• Accueil >
  • Publications >
  • Estrogen-Receptor, Progesterone-Receptor and HER2 Status Determination in Invasive Breast Cancer. Concordance between Immuno-Histochemistry and MapQuant™ Microarray Based Assay

Estrogen-Receptor, Progesterone-Receptor and HER2 Status Determination in Invasive Breast Cancer. Concordance between Immuno-Histochemistry and MapQuant™ Microarray Based Assay

1 févr. 2016PLOS ONE

DOI : 10.1371/journal.pone.0146474

Auteurs

D. Mouttet, M. Laé, M. Caly, D. Gentien, S. Carpentier, H. Peyro-Saint-Paul, A. Vincent-Salomon, R. Rouzier, B. Sigal-Zafrani, X. Sastre-Garau, F. Reyal

Membres

DAVID GENTIEN

Ingénieur de recherche